Acute Pancreatitis: Introduction
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Umbilical Hernia with Cholelithiasis and Hiatal Hernia
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Yamanaka et al. Surgical Case Reports (2015) 1:65 DOI 10.1186/s40792-015-0067-8 CASE REPORT Open Access Umbilical hernia with cholelithiasis and hiatal hernia: a clinical entity similar to Saint’striad Takahiro Yamanaka*, Tatsuya Miyazaki, Yuji Kumakura, Hiroaki Honjo, Keigo Hara, Takehiko Yokobori, Makoto Sakai, Makoto Sohda and Hiroyuki Kuwano Abstract We experienced two cases involving the simultaneous presence of cholelithiasis, hiatal hernia, and umbilical hernia. Both patients were female and overweight (body mass index of 25.0–29.9 kg/m2) and had a history of pregnancy and surgical treatment of cholelithiasis. Additionally, both patients had two of the three conditions of Saint’s triad. Based on analysis of the pathogenesis of these two cases, we consider that these four diseases (Saint’s triad and umbilical hernia) are associated with one another. Obesity is a common risk factor for both umbilical hernia and Saint’s triad. Female sex, older age, and a history of pregnancy are common risk factors for umbilical hernia and two of the three conditions of Saint’s triad. Thus, umbilical hernia may readily develop with Saint’s triad. Knowledge of this coincidence is important in the clinical setting. The concomitant occurrence of Saint’s triad and umbilical hernia may be another clinical “tetralogy.” Keywords: Saint’s triad; Cholelithiasis; Hiatal hernia; Umbilical hernia Background of our knowledge, no previous reports have described the Saint’s triad is characterized by the concomitant occur- coexistence of umbilical hernia with any of the three con- rence of cholelithiasis, hiatal hernia, and colonic diverticu- ditions of Saint’s triad. -
Cirrhosis of Liver Is a Risk Factor for Gallstone Disease
International Journal of Research in Medical Sciences Shirole NU et al. Int J Res Med Sci. 2017 May;5(5):2053-2056 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171841 Original Research Article Cirrhosis of liver is a risk factor for gallstone disease Nikhil U. Shirole*, Sudhir J. Gupta, Dharmesh K. Shah, Nitin R. Gaikwad, Tushar H. Sankalecha, Harit G. Kothari Department of Gastroenterology, Government Medical College and Super-speciality Hospital, Nagpur, Maharashtra, India Received: 07 February 2017 Revised: 22 March 2017 Accepted: 24 March 2017 *Correspondence: Dr. Nikhil U. Shirole, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Gallstones are common clinical finding in general population. Mean prevalence rate in Indian population is 4-5%. The prevalence of gallstones is found to be high in cirrhotic patients compared to the general population in some western studies. Cause of this increased prevalence however is not known. Aim of the study was to evaluate prevalence of the gall stones in the cirrhotic patients, assess risk factors in cirrhotic patients and clinical presentation. Methods: This is the cross sectional observational study, included cirrhotic patients (compensated or decompensated). Risk factors for gallstone formation (age, gender and diabetes mellitus), characteristics of liver cirrhosis (etiology, Child Turcotte Pugh class, hypersplenism and varices) and clinical presentation were assessed in all cirrhotic patients with gallstones. -
Case Report Acute Abdomen Caused by Brucellar Hepatic Abscess
Case Report Acute Abdomen Caused by Brucellar Hepatic Abscess Cem Ibis, Atakan Sezer, Ali K. Batman, Serkan Baydar, Alper Eker,1 Ercument Unlu,2 Figen Kuloglu,1 Bilge Cakir2 and Irfan Coskun, Departments of General Surgery, 1Infectious Diseases and 2Radiology, Faculty of Medicine, Trakya University, Edirne, Turkey. Brucellosis is a zoonotic infection that is transmitted from animals to humans by ingestion of infected food products, direct contact with an infected animal, or aerosol inhalation. The disease is endemic in many coun- tries, including the Mediterranean basin, the Middle East, India, Mexico, Central and South America and, central and southwest Asia. Human brucellosis is a systemic infection with a wide clinical spectrum. Although hepatic involvement is very common during the course of chronic brucellosis, hepatic abscess is a very rare complication of Brucella infection. We present a case of hepatic abscess caused by Brucella, which resembled the clinical presentation of surgical acute abdomen. [Asian J Surg 2007;30(4):283–5] Key Words: acute abdomen, Brucella, brucelloma, hepatic abscess, percutaneous drainage Introduction and high fever. His symptoms began 2 days before admis- sion. For the previous 2 weeks, he suffered from a slight Brucellosis is a zoonotic infection transmitted from ani- evening fever and associated sweating. Physical examina- mals to humans by ingestion of infected food products, tion revealed moderate splenomegaly, tenderness, abdom- direct contact with an infected animal, or inhalation of inal guarding, and rebound tenderness in the right upper aerosols.1 The disease remains endemic in many coun- quadrant. The symptoms of peritoneal irritation in the tries, mainly in the Mediterranean basin, the Middle East, right upper quadrant of the abdomen clinically suggested a India, Mexico, Central and South America and, currently, surgical acute abdomen. -
Complication Prevention for Patients with Diabetes a Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients
Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients The Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients results from the contributions and hard work of many people. Its development was led by Dr Hai-Rim Shin, Coordinator, and Dr Warrick Junsuk Kim, Medical Officer, of the Noncommunicable Diseases and Health Promotion unit at the WHO Regional Office for the Western Pacific (WHO/WPRO/NCD) in Manila, Philippines. WHO graciously acknowledges the intellectual contributions of Dr Jung-jin Cho, Co-director, Community-based Primary Care Project Committee and Professor, Department of Family Medicine, Hallym University Sacred Heart Dongtan Hospital, Republic of Korea; Dr Hyejin Lee, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Family Medicine, Seoul National University, Republic of Korea); Ms Saki Narita, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Global Health Policy, Graduate School of Medicine, University of Tokyo, Japan); and Mr Byung Ki Kwon, Technical Officer, WHO/WPRO/NCD (currently Director, Division of Health Promotion, Ministry of Health and Welfare, Republic of Korea). Many thanks to Dr Albert Domingo, Dr Sonia McCarthy, Ms Marie Clem Carlos, Dr Katrin Engelhardt, Mr Kelvin Khow Chuan Heng and Dr Roberto Andres Ruiz from the WHO Regional Office for the Western Pacific and Dr Ma. Charina Benedicto, Physician-in-Charge, Bagong Barangay Health Center & Lying-in Clinic, Pandacan, Manila, Philippines for reviewing the draft publication. Financial support for this publication was received from the Korea Centers for Disease Control and Prevention, Republic of Korea. -
Acute Pancreatitis Associated with Rotavirus Infection and Review Of
Case Report/Olgu Sunumu İstanbul Med J 2020; 21(1): 78-81 DO I: 10.4274/imj.galenos.2020.88319 Acute Pancreatitis Associated with Rotavirus Infection and Review of The Literature Rotavirüs Enfeksiyonuna Bağlı Akut Pankreatit Olguları ve Literatürün Gözden Geçirilmesi Kamil Şahin, Güzide Doğan University of Health Sciences, Haseki Training and Research Hospital, Department of Pediatrics, İstanbul, Turkey ABSTRACT ÖZ Agents causing acute gastroenteritis are not common causes of Çocuklarda pankreatit etiyolojisinde akut gastroenterit etkenleri pancreatitis etiology in children. Pancreatitis associated with sık görülen sebeplerden değildir. Rotavirüs enfeksiyonuna rotavirus infection is very rare. Cases with acute pancreatitis bağlı görülen pankreatit ise oldukça nadirdir. Rotavirüs during rotavirus gastroenteritis are reported due to rare gastroenteriti sırasında akut pankreatit gelişen olgular, associations. In this article, the causes of acute pancreatitis rotavirüs enfeksiyonuna bağlı akut pankreatitin nadir olması and cases of acute pancreatitis due to rotavirus infection were nedeniyle sunulmuştur. Bu yazıda, akut pankreatit sebepleri ve investigated. Clinical findings were mild, and complications rotavirüse bağlı gelişen akut pankreatit olguları incelenmiştir. were not observed in both of our patients, including a two- İki yaş kız ve üç yaşındaki erkek iki olgumuzda ve literatürde year-old female and a three-year-old male, and other cases değerlendirilen diğer olgularda klinik bulgular hafif seyretmiş, evaluated in the literature. The -
Risk Factors and Complications in Type 2 Diabetes Outpatients
RISKORIGINAL FACTORS AND COMPLICATIONS ARTICLE IN TYPE 2 DIABETES OUTPATIENTS Risk factors and complications in type 2 diabetes outpatients ELLEN FERNANDES FLávIO SILVA1, CRISTIANE MARIA MENDES FERREIRA2*, LUCINEIA DE PINHO3 1Medical Student, Faculdades Unidas do Norte de Minas (Funorte), Montes Claros, MG, Brazil 2Endocrinologist, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil 3PhD in Health Sciences, Unimontes and Funorte, Montes Claros, MG, Brazil SUMMARY Objective: Our study investigated type 2 diabetes mellitus (T2DM) outpatients attending a university hospital in Montes Claros, MG, to estimate the prevalence of risk factors and their association with diabetes complications. Method: This was a quantitative, documental, retrospective and analytical study. Medical records of 95 outpatients with T2DM treated in this hospital from 2011 to 2015 were analyzed. Data were collected according to a structured questionnaire surveying sociodemographic, anthropometric and biochemical data and clinical and lifestyle aspects. Regression analysis was used to evaluate the association between risk factor variables and complications. Results: With a mean age of 54 years, the study population showed irregular blood glucose control, despite the use of hypoglycemic medication, and did not Study conducted at Universidade have a healthy lifestyle. The main complication reported was high blood pressure Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil (HBP), occurring in 70.9% of patients. The prevalence of complications was positively associated with patients receiving insulin treatment (p=0.042) and Article received: 11/13/2016 Accepted for publication: 12/19/2016 multidisciplinary monitoring (p=0.050). Conclusion: The associations identified reflect the condition of patients that *Correspondence: Address: Av. Dr. -
Management of Travellers' Diarrhoea in Adults In
MANAGEMENT OF TRAVELLERS’ DIARRHOEA IN ADULTS IN PRIMARY CARE Homerton University Hospital and Hospital for Tropical Diseases December 2016 (review date December 2017) Presence of Assess as per NICE • Diarrhoea +/- nausea / vomiting and >3 loose stools per day guidelines on acute • PLUS travel outside of Western Europe / N America / Australia / diarrhoea New Zealand NO https://cks.nice.org • OR diarrhoea in men who have sex with other men (MSM) even in .uk/diarrhoea- the absence of foreign travel adults-assessment YES Refer to Homerton Infectious Diseases (ID) clinic (box Duration > 2 weeks 3) & commence stool investigations (MC&S, OCP +/- YES C difficle toxin test) NO Features of severe illness: • Fever >38.5 +/- bloody diarrhoea +/- severe abdominal pain OR • Immunocompromised (chemotherapy/ after tissue transplant/HIV with a low CD4 count) • Underlying intestinal pathology (inflammatory bowel disease/ ileostomy/short bowel syndrome) • Conditions where reduced oral intake may be dangerous (diabetes, sickle cell disease, elderly) YES Refer to YES • Dehydrated? Homerton • Evidence of sepsis? A&E (box 3) • Fever plus travel to malaria-endemic area NO • Acute abdomen/ signs suggestive of appendicitis? • Unable to manage at home/ clinician concern NO Diarrhoea with risk factors for severe illness/ Non-severe illness complications Investigations Investigations • Stool MC&S • Stool MC&S • Stool OC&P x 2 • Stool OC&P x 2 • C. difficile toxin test - if recent • C. difficile toxin test - if recent hospitalisation hospitalisation or antibiotics -
Mouth Esophagus Stomach Rectum and Anus Large Intestine Small
1 Liver The liver produces bile, which aids in digestion of fats through a dissolving process known as emulsification. In this process, bile secreted into the small intestine 4 combines with large drops of liquid fat to form Healthy tiny molecular-sized spheres. Within these spheres (micelles), pancreatic enzymes can break down fat (triglycerides) into free fatty acids. Pancreas Digestion The pancreas not only regulates blood glucose 2 levels through production of insulin, but it also manufactures enzymes necessary to break complex The digestive system consists of a long tube (alimen- 5 carbohydrates down into simple sugars (sucrases), tary canal) that varies in shape and purpose as it winds proteins into individual amino acids (proteases), and its way through the body from the mouth to the anus fats into free fatty acids (lipase). These enzymes are (see diagram). The size and shape of the digestive tract secreted into the small intestine. varies in each individual (e.g., age, size, gender, and disease state). The upper part of the GI tract includes the mouth, throat (pharynx), esophagus, and stomach. The lower Gallbladder part includes the small intestine, large intestine, The gallbladder stores bile produced in the liver appendix, and rectum. While not part of the alimentary 6 and releases it into the duodenum in varying canal, the liver, pancreas, and gallbladder are all organs concentrations. that are vital to healthy digestion. 3 Small Intestine Mouth Within the small intestine, millions of tiny finger-like When food enters the mouth, chewing breaks it 4 protrusions called villi, which are covered in hair-like down and mixes it with saliva, thus beginning the first 5 protrusions called microvilli, aid in absorption of of many steps in the digestive process. -
Pancreatic Cancer
A Patient’s Guide to Pancreatic Cancer COMPREHENSIVE CANCER CENTER Staff of the Comprehensive Cancer Center’s Multidisciplinary Pancreatic Cancer Program provided information for this handbook GI Oncology Program, Patient Education Program, Gastrointestinal Surgery Department, Medical Oncology, Radiation Oncology and Surgical Oncology Digestive System Anatomy Esophagus Liver Stomach Gallbladder Duodenum Colon Pancreas (behind the stomach) Anatomy of the Pancreas Celiac Plexus Pancreatic Duct Common Bile Duct Sphincter of Oddi Head Body Tail Pancreas ii A Patient’s Guide to Pancreatic Cancer ©2012 University of Michigan Comprehensive Cancer Center Table of Contents I. Overview of pancreatic cancer A. Where is the pancreas located?. 1 B. What does the pancreas do? . 2 C. What is cancer and how does it affect the pancreas? .....................2 D. How common is pancreatic cancer and who is at risk?. .3 E. Is pancreatic cancer hereditary? .....................................3 F. What are the symptoms of pancreatic cancer? ..........................4 G. How is pancreatic cancer diagnosed?. 7 H. What are the types of cancer found in the pancreas? .....................9 II. Treatment A. Treatment of Pancreatic Cancer. 11 1. What are the treatment options?. 11 2. How does a patient decide on treatment? ..........................12 3. What factors affect prognosis and recovery?. .12 D. Surgery. 13 1. When is surgery a treatment?. 13 2. What other procedures are done?. .16 E. Radiation therapy . 19 1. What is radiation therapy? ......................................19 2. When is radiation therapy given?. 19 3. What happens at my first appointment? . 20 F. Chemotherapy ..................................................21 1. What is chemotherapy? ........................................21 2. How does chemotherapy work? ..................................21 3. When is chemotherapy given? ...................................21 G. -
Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Children
Tropical Gastroenterology 2016;37(2):133-135 133 collection then follow the path along the lesser omentum References or gastrohepatic ligament toward the liver leading to the formation of left lobe subcapsular collections. Second 1. Mofredj A, Cadranel JF, Dautreaux Met al. Pancreatic mechanism, likely in our second case, is tracking of pseudocyst located in the liver: a case report and literature review. J Clin Gastroenterol. 2000;30:813. pancreatic juice along the hepatoduodenal ligament 2. Okuda K, Sugita S, Tsukada E, Sakuma Yet al. Pancreatic from the head of pancreas to the portahepatis resulting pseudocyst in the left hepatic lobe: a report of two cases. in formation of intrahepatic parenchymal collections. Hepatology. 1991;13:359-63. Pseudocysts, which form as per the first mechanism, 3. Kralik J, Pesula E. A pancreatic pseudocyst in the liver. are mainly subcapsular in location and are biconvex in Rozhl Chir. 1993;72:913. shape. Intra parenchymal pseudocysts formed as a result 4. Bhasin DK, Rana SS, Chandail VS et al. An intrahepatic pancreatic pseudocyst successfully treated endoscopic of the second mechanism are located away from the liver transpapillary drainage alone. JOP. 2005;6:5937. capsule and are located near branches of porta hepatis. 5. Atia A, Kalra S, Rogers M et al. A wayward cyst. JOP. J Intrahepatic pseudocysts pose a diagnostic challenge Pancreas (Online) 2009;10:4214. because they are rarely considered in the differential diagnosis of cystic hepatic lesions. Amylase rich fluid on aspiration and communication of pseudocyst with disrupted pancreatic duct on imaging is indicative of diagnosis. However, neither of pseudocysts in our two Non-alcoholic steatohepatitis cases had communication with pancreatic duct. -
Wound Classification
Wound Classification Presented by Dr. Karen Zulkowski, D.N.S., RN Montana State University Welcome! Thank you for joining this webinar about how to assess and measure a wound. 2 A Little About Myself… • Associate professor at Montana State University • Executive editor of the Journal of the World Council of Enterstomal Therapists (JWCET) and WCET International Ostomy Guidelines (2014) • Editorial board member of Ostomy Wound Management and Advances in Skin and Wound Care • Legal consultant • Former NPUAP board member 3 Today We Will Talk About • How to assess a wound • How to measure a wound Please make a note of your questions. Your Quality Improvement (QI) Specialists will follow up with you after this webinar to address them. 4 Assessing and Measuring Wounds • You completed a skin assessment and found a wound. • Now you need to determine what type of wound you found. • If it is a pressure ulcer, you need to determine the stage. 5 Assessing and Measuring Wounds This is important because— • Each type of wound has a different etiology. • Treatment may be very different. However— • Not all wounds are clear cut. • The cause may be multifactoral. 6 Types of Wounds • Vascular (arterial, venous, and mixed) • Neuropathic (diabetic) • Moisture-associated dermatitis • Skin tear • Pressure ulcer 7 Mixed Etiologies Many wounds have mixed etiologies. • There may be both venous and arterial insufficiency. • There may be diabetes and pressure characteristics. 8 Moisture-Associated Skin Damage • Also called perineal dermatitis, diaper rash, incontinence-associated dermatitis (often confused with pressure ulcers) • An inflammation of the skin in the perineal area, on and between the buttocks, into the skin folds, and down the inner thighs • Scaling of the skin with papule and vesicle formation: – These may open, with “weeping” of the skin, which exacerbates skin damage. -
797 Circulating Tumor DNA and Circulating Tumor Cells for Cancer
Medical Policy Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) Table of Contents • Policy: Commercial • Coding Information • Information Pertaining to All Policies • Policy: Medicare • Description • References • Authorization Information • Policy History • Endnotes Policy Number: 797 BCBSA Reference Number: 2.04.141 Related Policies Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer, #336 Policy1 Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Plasma-based comprehensive somatic genomic profiling testing (CGP) using Guardant360® for patients with Stage IIIB/IV non-small cell lung cancer (NSCLC) is considered MEDICALLY NECESSARY when the following criteria have been met: Diagnosis: • When tissue-based CGP is infeasible (i.e., quantity not sufficient for tissue-based CGP or invasive biopsy is medically contraindicated), AND • When prior results for ALL of the following tests are not available: o EGFR single nucleotide variants (SNVs) and insertions and deletions (indels) o ALK and ROS1 rearrangements o PDL1 expression. Progression: • Patients progressing on or after chemotherapy or immunotherapy who have never been tested for EGFR SNVs and indels, and ALK and ROS1 rearrangements, and for whom tissue-based CGP is infeasible (i.e., quantity not sufficient for tissue-based CGP), OR • For patients progressing on EGFR tyrosine kinase inhibitors (TKIs). If no genetic alteration is detected by Guardant360®, or if circulating tumor DNA (ctDNA) is insufficient/not detected, tissue-based genotyping should be considered. Other plasma-based CGP tests are considered INVESTIGATIONAL. CGP and the use of circulating tumor DNA is considered INVESTIGATIONAL for all other indications. 1 The use of circulating tumor cells is considered INVESTIGATIONAL for all indications.